LYCLEAR

This brand name is authorized in Australia, Ireland, Israel, Malta, UK.

Active ingredients

The drug LYCLEAR contains one active pharmaceutical ingredient (API):

1	Permethrin UNII 509F88P9SZ - PERMETHRIN
	The principal physiological action in insects (lice) exposed to permethrin is induction of electrochemical abnormalities across the membranes of excitable cells, leading to sensory hyperexcitability, inco-ordination and prostration. It is assumed that the mode of action against arachnids (mites) is similar.
	Read more about Permethrin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LYCLEAR Creme rinse	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)
LYCLEAR Cream	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
P03AC04	Permethrin	P Antiparasitic products, insecticides and repellents → P03 Ectoparasiticides, incl. scabicides, insecticides and repellents → P03A Ectoparasiticides, incl. scabicides → P03AC Pyrethrines, incl. synthetic compounds
Discover more medicines within P03AC04

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	3054R
GB	Medicines & Healthcare Products Regulatory Agency	33880, 33965
IE	Health Products Regulatory Authority	32292
IL	מִשְׂרַד הַבְּרִיאוּת	2987
MT	Medicines Authority	AA565/22402